RXO Receivables

The latest receivables for RXO is $1.2B as of March 2026. That compares with $1.2B in the prior-year period — up 5.7% year over year. Investors often review this figure alongside RXO's historical trend and sector peers before judging valuation or financial health.

Over the past year, RXO's receivables moved from $1.2B to $1.2B — a 5.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RXO's operating scale or balance-sheet position.

A receivables figure of $1.2B for RXO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RXO's receivables ($1.2B), review year-over-year change from $1.2B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.